NCT04779554 2026-04-01
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
Phase 2 Recruiting
Clinical Trials
10 trialsNCT06617897 2026-03-11
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
CSL Behring
Phase 3 Recruiting
NCT07451483 2026-03-05
Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Jules Bordet Institute
Recruiting
NCT06513065 2026-02-19
HIPEC-PMP
University of Southampton
Phase 3 Recruiting
NCT04024917 2026-01-16
COCOON
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Recruiting
NCT07341360 2026-01-14
Pseudovax
Oslo University Hospital
Phase EARLY_PHASE1 Recruiting
NCT07328737 2026-01-09
One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei
Beijing Tsinghua Chang Gung Hospital
Phase NA Recruiting
NCT06800391 2025-01-30
REVERSE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Recruiting
NCT01617382 2024-06-26
HIPEC
Universitaire Ziekenhuizen KU Leuven
Recruiting
NCT02073500 2021-07-28
PSM
Oslo University Hospital
Recruiting